The Pharmacist Role in Predicting and Improving Medication Adherence in Heart Failure Patients

Davis, Estella M.; Packard, Kathleen A.; Jackevicius, Cynthia A.

doi:10.18553/jmcp.2014.20.7.741

Cited by 38 publications

(46 citation statements)

References 66 publications

(137 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Poor medication adherence is a common problem in people with heart failure and has been associated with a higher risk for hospital admission, poor outcome, and death 32, 33. Medication adherence interventions have been shown to significantly reduce mortality risk and improve hospital readmission rates for human patients with heart failure 32, 33, 34…”

Section: Discussionmentioning

confidence: 99%

Association between Survival Time and Changes in NT‐proBNP in Cats Treated for Congestive Heart Failure

Pierce

Freeman

Cunningham

et al. 2017

Veterinary Internal Medicne

View full text Add to dashboard Cite

BackgroundReductions in N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) concentrations after treatment have been associated with improved survival in people with congestive heart failure (CHF), but have not been reported in cats with CHF.ObjectivesTo evaluate changes in NT‐proBNP concentrations in cats with CHF after treatment and determine whether serial NT‐proBNP measurements provide prognostic information.AnimalsThirty‐one client‐owned cats.MethodsProspective, observational study in cats with new onset CHF secondary to cardiomyopathy. Concentrations of NT‐proBNP were measured within 4 hours of admission to the hospital, on the day of discharge, and at re‐evaluation 7–10 days later.ResultsMedian NT‐proBNP concentrations decreased significantly from admission (1,713 pmol/L [range, 160–3,784 pmol/L]) to discharge (902 pmol/L [range, 147–3,223 pmol/L]); P = .005) and from admission to re‐evaluation (1,124 pmol/L [range, 111–2,727 pmol/L]; P = .024). Median survival time was 109 days (range, 1–709 days), with 5 cats still alive at the time of analysis. Cats with a larger percent decrease in NT‐proBNP from admission to discharge had a longer survival time (P = .048). Cats with evidence of active CHF at the time of re‐evaluation (P = .010) and cats whose owners had difficulty administering medications (P = .045) had shorter survival times.Conclusions and clinical importanceCats with a larger percent decrease in NT‐proBNP during hospitalization and no evidence of CHF at the time of re‐evaluation had longer survival times. Additional studies are needed to determine whether NT‐proBNP can help guide treatment in cats with CHF.

show abstract

Section: Discussionmentioning

confidence: 99%

Association between Survival Time and Changes in NT‐proBNP in Cats Treated for Congestive Heart Failure

Pierce

Freeman

Cunningham

et al. 2017

Veterinary Internal Medicne

View full text Add to dashboard Cite

show abstract

“…nurses and nutritionists) leads to a significant improvement in health condition, health-related quality of life, and beneficial modification of the patient's lifestyle. Such conclusions also result from the observation of patients with renal infarction, as indicated by Davis et al [10], where interrupted pharmaceutical care leads to a rapid loss of its positive effect on the health and quality of a patient's life. A few voices suggest that, in itself, even the best-designed, advanced pharmaceutical service, e.g.…”

Section: The Role Of the Pharmacist In The Process Of Optimising Pharmentioning

confidence: 86%

The role of the pharmacist in the care of patients with cardiovascular diseases

et al. 2016

View full text Add to dashboard Cite

“…7,8 Non-adherence to recommended treatment plans is common in CHF, 6,9 with reports that up to 60 % of patients do not adhere to their medication regimens as prescribed and up to 80 % do not adhere to lifestyle recommendations. 5,10 Van der Waal et al 6 also found that patients tend to tolerate exacerbations in their CHF symptoms and delay seeking assistance.…”

Section: Self-management Interventions In Chf: Do They Work?mentioning

confidence: 99%

“…4 Nonetheless, poor patient adherence is linked to hospital readmissions. 5,6 Patient disability, disease burden and decompensation undermine adherence to recommended self-management behaviours. 7,8 Non-adherence to recommended treatment plans is common in CHF, 6,9 with reports that up to 60 % of patients do not adhere to their medication regimens as prescribed and up to 80 % do not adhere to lifestyle recommendations.…”

Section: Self-management Interventions In Chf: Do They Work?mentioning

confidence: 99%

Patient Self-Management In Chronic Heart Failure — Establishing Concordance Between Guidelines And Practice

Toukhsati¹,

Driscoll²,

Hare³

2015

Cardiac Failure Review

View full text Add to dashboard Cite

The gold-standard of patient self-management in chronic heart failure (CHF) can be defined as "daily activities that maintain clinical stability". 1 This requires that patients monitor their symptoms, adhere to their medication, diet and exercise regimens and manage symptoms by recognising changes and responding by either adapting behaviours or by seeking appropriate assistance.2 Patient self-management is linked to reduced mortality risk and fewer hospital admissions; however, there is less certainty with regard to the benefits of some aspects of self-care, such as lifestyle choices and fluid restriction.2 According to the European Society of Cardiology Guidelines for the diagnosis and treatment of acute and chronic heart failure, 3 self-management is integral to achieving best patient outcomes: to reduce mortality and improve quality of life.Self-management in CHF usually involves behavioural adaptation.Patients may need to learn new behaviours, such as learning how to monitor and manage symptoms and complex medical regimens.Patients may also need to abstain (e.g. cease smoking), adapt (e.g. AbstractChronic heart failure (CHF) is a progressive and debilitating disease with a broad symptom profile, intermittently marked by periods of acute decompensation. CHF patients are encouraged to self-manage their illness, such as adhering to medical regimens and monitoring symptoms, to optimise health outcomes and quality of life. In so doing, patients are asked to collaborate with their health service providers with regard to their care. However, patients generally do not self-manage well, even with specialist support. Moreover, selfmanagement interventions are yet to demonstrate morbidity or mortality benefits. Social network approaches to self-management consider the availability and mobilisation of all resources, beyond those of only the patient and healthcare providers. Used in conjunction with e-health platforms, social network approaches may offer a means by which to optimise self-management programmes of the future.

show abstract

The Pharmacist Role in Predicting and Improving Medication Adherence in Heart Failure Patients

Cited by 38 publications

References 66 publications

Association between Survival Time and Changes in NT‐proBNP in Cats Treated for Congestive Heart Failure

Association between Survival Time and Changes in NT‐proBNP in Cats Treated for Congestive Heart Failure

The role of the pharmacist in the care of patients with cardiovascular diseases

Patient Self-Management In Chronic Heart Failure — Establishing Concordance Between Guidelines And Practice

Contact Info

Product

Resources

About